Pharmacodynamic characteristics of velkeid efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins
Aim. To ascertain individual sensitivity to veikeid in patients with resistant and recurrent multiple myeloma (MM) by determination of free light chains (FLC) of serum immunoglobulins. Material and methods. Forteen patients with MM stage III (Gcappa-5, Glambda-2, Acappa-3, Alambda-1, BJcappa-3) aged...
Main Authors: | Anatoliy Konstantinovich Golenkov, Tat'yana Alekseevna Mitina, Ivetta Nikolaevna Kogarko, Nina Vasil'evna Lyubimova, Elena Fedorovna Klinushkina, Anatoliy Yur'evich Baryshnikov, A K Golenkov, T A Mitina, I N Kogarko, N V Lyubimova, E F Klikushkina, A Yu Baryshnikov |
---|---|
Formato: | Artigo |
Idioma: | Russian |
Publicado: |
"Consilium Medicum" Publishing house
2009-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Acceso en liña: | https://ter-arkhiv.ru/0040-3660/article/view/30372 |
Títulos similares
-
Current methods of diagnosis and monitoring of a systemic amyloidosis course
por: Vilen Vilevich Rameev, et al.
Publicado: (2011-08-01) -
Clinical characteristics of velcade cumulative effect in resistant and recurrent multiple myeloma
por: T A Mitina, et al.
Publicado: (2008-07-01) -
Effectiveness of bortezomib and bortezomib-containing programs FOR the treatment of recurrent and resistant multiple myeloma
por: T A Mitina, et al.
Publicado: (2010-07-01) -
Concerning views of the Novgorod heretics
por: Grigorenko Anatoliy Yur’evich
Publicado: (2014-12-01) -
ASSESSMENT OF THE RESIDUAL TUMOR IN PATIENTS WITH MULTIPLE MYELOMA BASED ON THE ANALYSIS OF THE FREE LIGHT CHAINS OF IMMUNOGLOBULINS IN BLOOD SERUM
por: T. A. Мitina, et al.
Publicado: (2016-02-01)